Furthermore, imbalances between receptors and their ligands, such as VEGFR-3 and VEGF-C are potentially involved in the progression of NSCLC promoting lymph node metastasis (Takizawa et al. 2006). The gene discussed is FLT4; the disease is non-small cell lung carcinoma.